Item 5. Other Information
ITEM
5. OTHER INFORMATION
None.
35
ITEM
6. EXHIBITS
Incorporated
by Reference
Exhibit
Number
Exhibit
Description
Form
Exhibit
Filing
Date/Period End Date
10.1#
Director Agreement, dated April 26, 2024, between LifeMD, Inc. and Calum MacRae
8-K
10.1
05/02/2024
10.2#
Restricted Stock Award Agreement, dated April 26, 2024, between LifeMD, Inc. and Calum MacRae
8-K
10.2
05/02/2024
31.1*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.
31.2*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.
32.1**
Section 1350 Certification of Chief Executive Officer.
32.2**
Section 1350 Certification of Chief Financial Officer.
101.INS*
Inline
XBRL Instance Document
101.SCH*
Inline
XBRL Taxonomy Extension Schema Document
101.CAL*
Inline
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
Inline
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline
XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
Inline
XBRL Taxonomy Extension Presentation Linkbase Document
104*
Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)
#
Indicates management contract or compensatory plan, contract or arrangement.
*
Filed herewith.
**Furnished
herewith
36
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
LIFEMD,
INC.
By:
/s/
Justin Schreiber
Justin
Schreiber
Chief
Executive Officer and Chairman of the Board of Directors
Date:
May
8, 2024
By:
/s/
Marc Benathen
Marc
Benathen
Chief
Financial Officer
Date:
May
8, 2024
By:
/s/
Maria Stan
Maria
Stan
Chief
Accounting Officer
Date:
May
8, 2024
37
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.